Disease | candidiasis |
Comorbidity | C0026946|fungal infections |
Sentences | 2 |
PubMedID- 24084636 | Objectives: the objective of this study was to estimate the population pharmacokinetics of voriconazole, to identify the factors influencing voriconazole pharmacokinetics and to identify optimal dosage regimens for attaining target pharmacokinetic/pharmacodynamic indices against aspergillus and candida infections in patients with invasive fungal infections (ifis). |
PubMedID- 21799572 | Those who did not get counseling from ictc, patients who felt that visitors increased to “check them out”, those experiencing fungal infections of nail or oral candidiasis were at a higher risk. |
Page: 1